Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Cancer|April 15, 2021
Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progressionNapat Armartmuntree, Apinya Jusakul, Chadamas Sakonsinsiri, et al.
Scientific Reports|March 29, 2025
Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinomaSirinya Sitthirak, Arporn Wangwiwatsin, Apinya Jusakul, et al.
Medical Sciences (Basel, Switzerland)|January 21, 2026
Integrative Sequencing and Proteogenomic Approaches to Intratumoral Heterogeneity in Cholangiocarcinoma: Implications for Precision Diagnosis and TherapySirinya Sitthirak, Arporn Wangwiwatsin, Apinya Jusakul, et al.
Scientific Reports|March 13, 2025
Establishment and genomic profiling of cholangiocarcinoma cells with functional characterizationRattanaporn Jaidee, Apinya Jusakul, Piman Pocasap, et al.
Cancers|February 24, 2024
Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic ApproachesDivya Khosla, Shagun Misra, Pek Lim Chu, et al.
JCO Global Oncology|April 22, 2020
Lack of Targetable FGFR2 Fusions in Endemic Fluke-Associated CholangiocarcinomaSarinya Kongpetch, Apinya Jusakul, Jing Quan Lim, et al.
Genome Research|July 26, 2017
Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumorsMi Ni Huang, Willie Yu, Wei Wei Teoh, et al.
Nature Genetics|November 5, 2013
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancersWaraporn Chan-On, Maarja-Liisa Nairismägi, Choon Kiat Ong, et al.
Cancer Discovery|March 22, 2017
Epigenomic Promoter Alterations Amplify Gene Isoform and Immunogenic Diversity in Gastric AdenocarcinomaAditi Qamra, Manjie Xing, Nisha Padmanabhan, et al.
Pageof 6